Shire Hits Sandoz With Second Suit Over Generic Intuniv

Drugmaker Shire on Monday hit rival Sandoz with a second patent suit in Colorado federal court over Sandoz’s proposal to manufacture a generic version of the attention deficit hyperactivity disorder drug Intuniv.
Law360